APA (7th ed.) Citation

Paterson, A. H., Anderson, S. J., Lembersky, B. C., Fehrenbacher, L., Falkson, C. I., King, K. M., . . . Wolmark, N. (2012). Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): A multicentre, placebo-controlled, randomised trial. The lancet oncology, 13(7), 734-742. https://doi.org/10.1016/S1470-2045(12)70226-7

Chicago Style (17th ed.) Citation

Paterson, Alexander HG, et al. "Oral Clodronate for Adjuvant Treatment of Operable Breast Cancer (National Surgical Adjuvant Breast and Bowel Project Protocol B-34): A Multicentre, Placebo-controlled, Randomised Trial." The Lancet Oncology 13, no. 7 (2012): 734-742. https://doi.org/10.1016/S1470-2045(12)70226-7.

MLA (9th ed.) Citation

Paterson, Alexander HG, et al. "Oral Clodronate for Adjuvant Treatment of Operable Breast Cancer (National Surgical Adjuvant Breast and Bowel Project Protocol B-34): A Multicentre, Placebo-controlled, Randomised Trial." The Lancet Oncology, vol. 13, no. 7, 2012, pp. 734-742, https://doi.org/10.1016/S1470-2045(12)70226-7.